Panel Discussion: Evaluating Clinical Progress, Commercial Milestones & Emerging Opportunities to Shape the Future of Complement Therapeutics

• Reviewing the latest clinical trial readouts, approvals and pipeline developments that are redefining the complement therapeutic landscape
• Distilling lessons from recent industry headlines, strategic collaborations and development challenges to guide future innovation and portfolio decisions
• Recapping recent development and strategizing the future of complement therapeutics

Speakers:

Peter Zipfel

Professor

International Leibniz Research School

Karthik Viswanathan

Vice President, Research

Visterra

Michael Storek

Independent Complement Expert